
Malcolm Cribbs
Examiner (ID: 10271, Phone: (571)270-1566 , Office: P/2497 )
| Most Active Art Unit | 2497 |
| Art Unit(s) | 2432, 2497, 2115 |
| Total Applications | 956 |
| Issued Applications | 839 |
| Pending Applications | 36 |
| Abandoned Applications | 93 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19170817
[patent_doc_number] => 20240156791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => METHODS OF TREATING SPINAL CORD INJURY OR DAMAGE
[patent_app_type] => utility
[patent_app_number] => 18/277901
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17748
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18277901
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/277901 | METHODS OF TREATING SPINAL CORD INJURY OR DAMAGE | Feb 17, 2022 | Pending |
Array
(
[id] => 19423690
[patent_doc_number] => 12083081
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-10
[patent_title] => Sterile aqueous choline salt compositions
[patent_app_type] => utility
[patent_app_number] => 17/672549
[patent_app_country] => US
[patent_app_date] => 2022-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15100
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17672549
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/672549 | Sterile aqueous choline salt compositions | Feb 14, 2022 | Issued |
Array
(
[id] => 18018910
[patent_doc_number] => 20220370409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => Compositions And Methods For The Treatment Of Depression
[patent_app_type] => utility
[patent_app_number] => 17/670123
[patent_app_country] => US
[patent_app_date] => 2022-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25245
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17670123
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/670123 | Compositions and methods for the treatment of depression | Feb 10, 2022 | Issued |
Array
(
[id] => 19497544
[patent_doc_number] => 20240336562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-10
[patent_title] => COMPOUND SERVING AS NLRP3 INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 18/264949
[patent_app_country] => US
[patent_app_date] => 2022-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16405
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18264949
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/264949 | COMPOUND SERVING AS NLRP3 INHIBITOR | Feb 9, 2022 | Pending |
Array
(
[id] => 17625693
[patent_doc_number] => 20220160708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => Methods and Compositions for Reducing Side Effects in Chemotherapeutic Treatments
[patent_app_type] => utility
[patent_app_number] => 17/650270
[patent_app_country] => US
[patent_app_date] => 2022-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5742
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17650270
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/650270 | Methods and Compositions for Reducing Side Effects in Chemotherapeutic Treatments | Feb 7, 2022 | Abandoned |
Array
(
[id] => 19049226
[patent_doc_number] => 20240091195
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => MEDICINE COMPRISING GLYCOPYRRONIUM SALICYLATE
[patent_app_type] => utility
[patent_app_number] => 18/272769
[patent_app_country] => US
[patent_app_date] => 2022-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5463
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18272769
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/272769 | MEDICINE COMPRISING GLYCOPYRRONIUM SALICYLATE | Feb 3, 2022 | Abandoned |
Array
(
[id] => 20226304
[patent_doc_number] => 12414944
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-16
[patent_title] => Methods of treating fabry disease in patients having the G9331A mutation in the GLA gene
[patent_app_type] => utility
[patent_app_number] => 17/588943
[patent_app_country] => US
[patent_app_date] => 2022-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 13
[patent_no_of_words] => 5807
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17588943
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/588943 | Methods of treating fabry disease in patients having the G9331A mutation in the GLA gene | Jan 30, 2022 | Issued |
Array
(
[id] => 17593348
[patent_doc_number] => 20220142921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => ENEMA FOR RECTAL APPLICATION
[patent_app_type] => utility
[patent_app_number] => 17/581354
[patent_app_country] => US
[patent_app_date] => 2022-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4950
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17581354
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/581354 | Enema for rectal application | Jan 20, 2022 | Issued |
Array
(
[id] => 17576826
[patent_doc_number] => 20220133681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => METHOD OF TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/648046
[patent_app_country] => US
[patent_app_date] => 2022-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2576
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17648046
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/648046 | METHOD OF TREATMENT | Jan 13, 2022 | Abandoned |
Array
(
[id] => 17576835
[patent_doc_number] => 20220133690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => Pharmaceutical Composition for Treatment of Bone-Related Disease
[patent_app_type] => utility
[patent_app_number] => 17/575162
[patent_app_country] => US
[patent_app_date] => 2022-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6883
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17575162
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/575162 | Pharmaceutical Composition for Treatment of Bone-Related Disease | Jan 12, 2022 | Abandoned |
Array
(
[id] => 17532239
[patent_doc_number] => 20220110848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => PHOTOPROTECTIVE COMPOSITIONS CONTAINING MALASSEZIA-DERIVED COMPOUNDS AND/OR CHEMICAL ANALOGS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/556778
[patent_app_country] => US
[patent_app_date] => 2021-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28197
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17556778
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/556778 | Photoprotective compositions containing | Dec 19, 2021 | Issued |
Array
(
[id] => 18449410
[patent_doc_number] => 20230190686
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => COMPOSITION AND METHOD FOR TREATMENT OF DIABETES
[patent_app_type] => utility
[patent_app_number] => 17/554076
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3755
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17554076
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/554076 | COMPOSITION AND METHOD FOR TREATMENT OF DIABETES | Dec 16, 2021 | Abandoned |
Array
(
[id] => 17655261
[patent_doc_number] => 20220175726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => STABLE PRESERVATIVE-FREE MYDRIATIC AND ANTI-INFLAMMATORY SOLUTIONS FOR INJECTION
[patent_app_type] => utility
[patent_app_number] => 17/552872
[patent_app_country] => US
[patent_app_date] => 2021-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13434
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17552872
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/552872 | Stable preservative-free mydriatic and anti-inflammatory solutions for injection | Dec 15, 2021 | Issued |
Array
(
[id] => 19297494
[patent_doc_number] => 20240226059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => COMPOSITION FOR INHIBITING ANGIOGENESIS AND ENHANCING THERAPEUTIC EFFECT OF ANTICANCER DRUGS IN CANCER PATIENT
[patent_app_type] => utility
[patent_app_number] => 18/267205
[patent_app_country] => US
[patent_app_date] => 2021-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3041
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18267205
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/267205 | COMPOSITION FOR INHIBITING ANGIOGENESIS AND ENHANCING THERAPEUTIC EFFECT OF ANTICANCER DRUGS IN CANCER PATIENT | Dec 14, 2021 | Pending |
Array
(
[id] => 19716119
[patent_doc_number] => 12201634
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-21
[patent_title] => Methods of treating depression using orexin-2 receptor antagonists
[patent_app_type] => utility
[patent_app_number] => 17/551955
[patent_app_country] => US
[patent_app_date] => 2021-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 16
[patent_no_of_words] => 12024
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17551955
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/551955 | Methods of treating depression using orexin-2 receptor antagonists | Dec 14, 2021 | Issued |
Array
(
[id] => 19624086
[patent_doc_number] => 12162890
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-10
[patent_title] => Heteroaromatic NMDA receptor modulators and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/550435
[patent_app_country] => US
[patent_app_date] => 2021-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73018
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 672
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17550435
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/550435 | Heteroaromatic NMDA receptor modulators and uses thereof | Dec 13, 2021 | Issued |
Array
(
[id] => 18842549
[patent_doc_number] => 20230404953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => COMPOUND FOR THE REDUCTION OF WHITE ADIPOSE TISSUE AND THE TREATMENT OF OVERWEIGHT AND OBESITY
[patent_app_type] => utility
[patent_app_number] => 18/254618
[patent_app_country] => US
[patent_app_date] => 2021-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9477
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18254618
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/254618 | COMPOUND FOR THE REDUCTION OF WHITE ADIPOSE TISSUE AND THE TREATMENT OF OVERWEIGHT AND OBESITY | Dec 9, 2021 | Abandoned |
Array
(
[id] => 17655278
[patent_doc_number] => 20220175743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => TOPICAL ROFLUMILAST FORMULATION HAVING ANTIFUNGAL PROPERTIES
[patent_app_type] => utility
[patent_app_number] => 17/542072
[patent_app_country] => US
[patent_app_date] => 2021-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6926
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17542072
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/542072 | Topical roflumilast formulation having antifungal properties | Dec 2, 2021 | Issued |
Array
(
[id] => 17576823
[patent_doc_number] => 20220133678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => METHOD FOR TREATMENT OF ROSACEA
[patent_app_type] => utility
[patent_app_number] => 17/541847
[patent_app_country] => US
[patent_app_date] => 2021-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13029
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 205
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17541847
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/541847 | Method for treatment of rosacea | Dec 2, 2021 | Issued |
Array
(
[id] => 17768151
[patent_doc_number] => 11400069
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-02
[patent_title] => Methods of treating mixed dyslipidemia
[patent_app_type] => utility
[patent_app_number] => 17/457160
[patent_app_country] => US
[patent_app_date] => 2021-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 23856
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17457160
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/457160 | Methods of treating mixed dyslipidemia | Nov 30, 2021 | Issued |